Biotron Limited
OTC: BITRF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michelle Miller GCertAppFin
- Employees
- 3
- Headquarters
- Sydney, Australia
- IPO year
- 2013
- Market cap
- $1.8M
- Website
- https://www.biotron.com.au
Loading BITRF…
Loading profile data…Frequently asked questions about BITRF
What does Biotron Limited (BITRF) do?
Biotron Limited is an Australian biotechnology firm focused on the development and market introduction of small-molecule compounds designed to combat various viral infections. The company's primary antiviral agent, BIT225, is currently undergoing Phase II clinical trials to assess its efficacy against SARS-CoV-2, HIV-1, and hepatitis C virus inf...
Where does BITRF trade?
Biotron Limited (BITRF) trades on the Other OTC.
What sector is BITRF in?
Biotron Limited (BITRF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biotron Limited?
Michelle Miller GCertAppFin is the chief executive officer of Biotron Limited (BITRF).
Where is Biotron Limited headquartered?
Biotron Limited is headquartered in Australia.
Does BITRF pay a dividend?
Biotron Limited (BITRF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BITRF go public?
Biotron Limited (BITRF) completed its initial public offering in 2013.